Resources from the same session
Randomised versus real-world evidence on the efficacy and toxicity of checkpoint inhibitors
Presenter: Timothée Olivier
Session: Real-world benefit of immunotherapy
Resources:
Slides
Webcast
Prediction of immune checkpoint inhibitor outcome and side effects by use of machine learning and routine real-world data
Presenter: Travis Osterman
Session: Real-world benefit of immunotherapy
Resources:
Slides
Webcast
Impact of real-world data on clinical treatment guidelines for immune therapy
Presenter: Marco Donia
Session: Real-world benefit of immunotherapy
Resources:
Slides
Webcast
Q&A and discussion
Session: Real-world benefit of immunotherapy
Resources:
Webcast